[Development of pregnancy in genetic risk patients with special reference to transabdominal amniocentesis].
A complex 3-stage-method of pregnancy evaluation in genetic patients with a planned-transabdominal amniocentesis reduces essentially the risk of the intervention; the state of maternal organism, placental function and fetal growth are repeatedly assessed. Fetal growth retardation together with poor placental function indicated in 4 cases a malformation of the type not be able to be diagnosed cytogeneticylla. Our experience is derived from 404 pregnancies followed before and after transabdominal amniocentesis.
D000649:Amniocentesis; D006063:Chorionic Gonadotropin / Q000652:urine; D004958:Estradiol / Q000652:urine; D005260:Female; D005323:Fetal Monitoring; D005500:Follow-Up Studies; D030342:Genetic Diseases, Inborn / Q000175:diagnosis* / Q000652:urine; D006801:Humans; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011262:Pregnancy Trimester, Second; D011263:Pregnancy Trimester, Third; D012306:Risk
D006063:Chorionic Gonadotropin; D004958:Estradiol
Die Entwicklung der Schwangerschaft bei genetischen Risikopatientinnen unter besonderer Berücksichtigung der transabdominalen Amniozentese.